DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 40 filers reported holding DECIBEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,823,477 | -42.8% | 1,865,111 | -3.5% | 0.00% | 0.0% |
| Q3 2022 | $6,686,000 | -21.5% | 1,932,286 | -4.4% | 0.00% | -50.0% |
| Q2 2022 | $8,513,000 | +52.5% | 2,021,908 | +10.1% | 0.00% | +100.0% |
| Q1 2022 | $5,581,000 | -34.3% | 1,835,891 | +0.5% | 0.00% | -50.0% |
| Q4 2021 | $8,495,000 | -38.0% | 1,826,961 | +2.8% | 0.00% | -33.3% |
| Q3 2021 | $13,706,000 | -8.2% | 1,777,659 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $14,935,000 | -26.1% | 1,773,831 | -0.3% | 0.00% | -40.0% |
| Q1 2021 | $20,203,000 | – | 1,778,396 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $9,545,000 | 2.59% |
| Samsara BioCapital, LLC | 826,422 | $2,512,000 | 0.63% |
| Orbimed Advisors | 4,945,192 | $15,033,000 | 0.24% |
| Alphabet Inc. | 1,636,258 | $4,974,000 | 0.16% |
| HARVARD MANAGEMENT CO INC | 328,798 | $1,000,000 | 0.10% |
| Casdin Capital, LLC | 330,000 | $1,003,000 | 0.04% |
| Bronte Capital Management Pty Ltd. | 163,224 | $496,000 | 0.04% |
| MYDA Advisors LLC | 20,000 | $61,000 | 0.02% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 263,600 | $801,000 | 0.02% |
| ATLAS CAPITAL ADVISORS LLC | 41,025 | $124,716,000 | 0.02% |